Factors influencing the shift of patients from one proton pump inhibitor to another: The effect of direct-to-consumer advertising

This publication has 15 references indexed in Scilit:

• The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use☆
  Research in Social and Administrative Pharmacy, 2005
• Who is using chronic acid suppression therapy and why?
  American Journal of Gastroenterology, 2003
• Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients
  American Journal of Gastroenterology, 2001
• Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials
  Clinical Therapeutics, 2001
• Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
  Alimentary Pharmacology & Therapeutics, 2000
• Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole.
  Archives of internal medicine (1960), 2000
• Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitor
  Alimentary Pharmacology & Therapeutics, 2000
• Evaluation of omeprazole as a cost‐effective diagnostic test for gastro‐oesophageal reflux disease
  Alimentary Pharmacology & Therapeutics, 1999
• Advertising as Information
  Journal of Political Economy, 1974
• Information and Consumer Behavior
  Journal of Political Economy, 1970